ARTICLE | Company News
Bavarian Nordic, NIH infectious news
August 3, 2015 7:00 AM UTC
NIH’s National Institute of Allergy and Infectious Diseases (NIAID) exercised contract options under a 2012 deal with Bavarian Nordic to develop a Filovirus vaccine. The options will provide an additi...